show dates: November 28-30, 2023
location: Greater Noida, Delhi, India
booth: 8.R08
Ashland’s team of solvers is looking forward to seeing you at CPHI India 2023. You will have the opportunity to discover our newest products.
The team will be on hand to discuss the industry’s most complete portfolio of controlled release products for any and all release profiles, other excipient dosage forms, and additional products for the parenteral segment, such as cyclodextrins and high purity Vialose™ trehalose dihydrate, a functional ingredient used to protect and stabilize proteins for biologic medicines.
Ask us about Aquarius™ TF titanium free coatings system that addresses recent industry and marketplace concerns.
When you're ready to formulate, we're ready to work with you.
at CPHI Ashland will introduce:
And we are featuring recent additions to our portfolio :
- polyplasdone™ plus multifunctional disintegrant is a direct compression superdisintegrant containing silica and lubricant. This highly effective new product provides enhanced flow properties, self-lubrication, and enhanced tablet performance, improving overall manufacturing through-put time.
- vialose™ trehalose dihydrate is a premier performance sugar resistant to acid hydrolysis and enzymatic cleavage. It is used to protect and shield biologic APIs, recombinant proteins, and monoclonal antibodies (mAbs) from degradation and aggregation and to stabilize and protect valuable components during the lyophilization process.
- klucel™ xtend hydroxypropyl cellulose (HPC) controlled release matrix former, designed to deliver unsurpassed process versatility and release profile efficiency. It is the latest addition to our Klucel™ product line and further expands our controlled-release portfolio. Ashland’s step change klucel™ xtend HPC, has been shown to match the release profile of hypromellose controlled-release formulations at half the polymer concentration.
- aquarius™ film-coating systems are our line of fully formulated, easily dispersed and ready-to-use have a range of functions to meet your needs: aesthetic or functional coatings, white or colored, with or without TiO2.
We offer the broadest selection of ingredients to compose effective pharmaceutical excipients. Migrating towards high impact and high value, we are widening our portfolio of cellulose-based polymers (HPMC, HPC, CMC, HEC), growing our excipient portfolio for injectables/biologics, including the possibility for customization, and focusing on film coatings. Oral solid dosage and liquid dosage ingredients, controlled release functionality, coatings, disintegrants, binders, and now, injectables compose Ashland’s pharma portfolio, and it is the diamond at the center of Ashland.
